BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 27007621)

  • 1. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
    Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
    ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma.
    Fan B; Kang L; Chen L; Sun P; Jin M; Wang Q; Bae YH; Huang W; Gao Z
    Theranostics; 2017; 7(2):357-376. PubMed ID: 28042340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
    Xu C; Wang P; Zhang J; Tian H; Park K; Chen X
    Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylboronic acid-sugar grafted polymer architecture as a dual stimuli-responsive gene carrier for targeted anti-angiogenic tumor therapy.
    Kim J; Lee YM; Kim H; Park D; Kim J; Kim WJ
    Biomaterials; 2016 Jan; 75():102-111. PubMed ID: 26491998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier.
    Wang J; Dou B; Bao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP-Responsive Low-Molecular-Weight Polyethylenimine-Based Supramolecular Assembly via Host-Guest Interaction for Gene Delivery.
    Jiang C; Qi Z; Jia H; Huang Y; Wang Y; Zhang W; Wu Z; Yang H; Liu J
    Biomacromolecules; 2019 Jan; 20(1):478-489. PubMed ID: 30516950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
    Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An effective tumor-targeting strategy utilizing hypoxia-sensitive siRNA delivery system for improved anti-tumor outcome.
    Kang L; Fan B; Sun P; Huang W; Jin M; Wang Q; Gao Z
    Acta Biomater; 2016 Oct; 44():341-54. PubMed ID: 27545812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible Covalent Cross-Linked Polycations with Enhanced Stability and ATP-Responsive Behavior for Improved siRNA Delivery.
    Zhou Z; Zhang M; Liu Y; Li C; Zhang Q; Oupicky D; Sun M
    Biomacromolecules; 2018 Sep; 19(9):3776-3787. PubMed ID: 30081638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional selenium nanoparticles as carriers of HSP70 siRNA to induce apoptosis of HepG2 cells.
    Li Y; Lin Z; Zhao M; Xu T; Wang C; Xia H; Wang H; Zhu B
    Int J Nanomedicine; 2016; 11():3065-76. PubMed ID: 27462151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
    Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
    Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
    Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
    Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model.
    Ben David-Naim M; Grad E; Aizik G; Nordling-David MM; Moshel O; Granot Z; Golomb G
    Biomaterials; 2017 Nov; 145():154-167. PubMed ID: 28863309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
    Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
    Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
    Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC
    J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy.
    Yang Z; Duan J; Wang J; Liu Q; Shang R; Yang X; Lu P; Xia C; Wang L; Dou K
    Int J Nanomedicine; 2018; 13():1851-1865. PubMed ID: 29618926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapy.
    Zhou Z; Zhang Q; Zhang M; Li H; Chen G; Qian C; Oupicky D; Sun M
    Theranostics; 2018; 8(17):4604-4619. PubMed ID: 30279726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy.
    Xia Y; Guo M; Xu T; Li Y; Wang C; Lin Z; Zhao M; Zhu B
    Int J Nanomedicine; 2018; 13():1539-1552. PubMed ID: 29588583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.